Filing Details

Accession Number:
0001567619-18-001424
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-17 20:46:47
Reporting Period:
2018-08-15
Accepted Time:
2018-08-17 20:46:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1433714 Castlight Health Inc. CSLT Services-Computer Processing & Data Preparation (7374) 261989091
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1742487 Maeve O'meara C/O Castlight Health, Inc.
150 Spear St., Suite 400
San Francisco CA 94105
Evp,Product&Customerexperience No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class B Common Stock Acquisiton 2018-08-15 9,000 $0.00 39,881 No 4 M Direct
Class B Common Stock Disposition 2018-08-16 3,284 $2.87 36,597 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class B Common Stock Restricted Stock Units Disposition 2018-08-15 9,000 $0.00 9,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,000 No 4 M Direct
Footnotes
  1. Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on May 15, 2015, the grant of which was previously reported by the ReportingPerson on a Form 3.
  2. Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSU's. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
  3. Represents the weighted average sales price per share. The shares sold at prices ranging from $2.85 to $2.875 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  4. Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration.
  5. 25% of the RSUs vested on February 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting.